Europe: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment

Europe: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment

 

 

European Medicines Agency
News & Press Releases
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14 October 2021 (new)
CHMP, Last updated: 15/10/2021

 

 

News: EMA starts rolling review of Evusheld (tixagevimab and cilgavimab) (new)
CHMP, Last updated: 14/10/2021

 

 

News: EMA ends rolling review of CVnCoV COVID-19 vaccine following withdrawal by CureVac AG (new)
Last updated: 12/10/2021

 

 

News: EMA receives application for marketing authorisation for Ronapreve (casirivimab / imdevimab) for treatment and prevention of COVID-19 (new)
CHMP, PDCO, PRAC, Last updated: 11/10/2021

 

 

::::::

 

European Centre for Disease Prevention and Control
https://www.ecdc.europa.eu/en
Latest Updates
News
ECDC supports Member States to increase COVID-19 vaccination acceptance and uptake in the EU/EEA
News story – 15 Oct 2021

Publication
Facilitating COVID-19 vaccination acceptance and uptake in the EU/EEA
Technical report – 15 Oct 2021

 

 

::::::

Accessed 16 Oct 2021
https://vaccinetracker.ecdc.europa.eu/public/extensions/COVID-19/vaccine-tracker.html#uptake-tab

 

 

::::::
European Commission
https://ec.europa.eu/commission/presscorner/home/en
Press release 12 October 2021
Afghanistan: Commission announces €1 billion Afghan support package
During the G20 meeting on Afghanistan, President of the European Commission, Ursula von der Leyen, will announce a support package worth around €1 billion for the Afghan people and neighbouring countries, addressing the urgent needs in the country and the region.

Press release 11 October 2021
EU announces vital €92 million contribution in support of UNRWA’s operations
The European Union has disbursed an essential payment of €92 million to the United Nations Relief and Works Agency for Palestine Refugees (UNRWA).

Questions and answers 11 October 2021
Questions and Answers: Proposal to amend EU Budget for 2021 to support global vaccination and funding for global emergencies.
… What is Draft Amending Budget 6 about? 
Draft Amending Budget 6 is about providing additional support to policy areas, which need reinforcement in view of recent developments and additional needs.
More concretely, with the additional funds that Draft Amending Budget 6 will provide, the EU will be able to help speed up global vaccinations, ensure funding for global emergencies like repatriation flights from Afghanistan, reinforce the EU response to the disasters in Haiti and outstanding operations including fighting forest fires and address other pending issues.
Why is the Commission proposing to reinforce the Neighbourhood, Development and International Cooperation Instrument?
With less than 1% of global doses of vaccine for COVID-19 having been administered in low and lower-middle income countries, there is a clear and pressing need to speed up global vaccinations. The EU has already committed to share 250 million doses and stands ready to provide an additional 200 million doses to low and middle income countries through COVAX, at the latest by mid-2022. To secure these extra doses, a total of €1.3 billion will be needed. Of this total amount, €850 million are already available within existing EU budget instruments. The Draft Amending Budget 6 will provide the additional €450 million that are still needed to reach the full €1.3 billion. This is possible by mobilising the EU Flexibility Instrument, which is specifically designed to provide funding for new or unforeseen policy developments…